Cargando…
Exploration and validation of radiomics signature as an independent prognostic biomarker in stage III-IVb nasopharyngeal carcinoma
There is no consensus on specific prognostic biomarkers potentially improving survival of nasopharyngeal carcinoma (NPC), especially in advanced-stage disease. The prognostic value of MRI-based radiomics signature is unclear. A total of 970 quantitative features were extracted from the tumor of 100...
Autores principales: | Ouyang, Fu-Sheng, Guo, Bao-Liang, Zhang, Bin, Dong, Yu-Hao, Zhang, Lu, Mo, Xiao-Kai, Huang, Wen-Hui, Zhang, Shui-Xing, Hu, Qiu-Gen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650385/ https://www.ncbi.nlm.nih.gov/pubmed/29088830 http://dx.doi.org/10.18632/oncotarget.20423 |
Ejemplares similares
-
Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case–control study
por: Li, Yang, et al.
Publicado: (2017) -
Longitudinal Trend of Health-Related Quality of Life During Concurrent Chemoradiotherapy and Survival in Patients With Stage II–IVb Nasopharyngeal Carcinoma
por: Li, Ji-Bin, et al.
Publicado: (2020) -
Prognostic and predictive value of radiomics signatures in stage I‐III colon cancer
por: Dai, Weixing, et al.
Publicado: (2020) -
The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis
por: Zhi-Qiang, Wang, et al.
Publicado: (2019) -
Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer
por: Aoki, Yoichi, et al.
Publicado: (2018)